A study for a 27 year old woman who takes Viibryd, Amphetamine Salt Combo, Xanax - from FDA reports

312 females aged 27 (±5) who take the same drugs are studied. This is a personalized study for a 27 year old female patient who has Depression, Attention Deficit Hyperactivity Disorder (Adhd), Ptsd. The study is created by eHealthMe based on reports from FDA.

On Jun, 12, 2018

312 females aged 27 (±5) who take Viibryd, Amphetamine Salt Combo, Xanax are studied.

Number of reports submitted per year:

Viibryd, Amphetamine Salt Combo, Xanax for a 27-year old woman.

Information of the patient in this study:

  • Age: 27
  • Gender: female
  • Conditions: Depression, Attention Deficit Hyperactivity Disorder (Adhd), Ptsd
  • Drugs taken:
    • Viibryd (vilazodone hydrochloride)
    • Amphetamine Salt Combo (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate)
    • Xanax (alprazolam)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Shortness Of Breath: 0 (0% of females aged 27 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  1. Feeling abnormal
  2. Abnormal dreams
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Nausea and vomiting
  5. Pulmonary function test decreased
1 - 6 months:
  1. Suicidal ideation
  2. Fainting (loss of consciousness and postural tone)
  3. Headache (pain in head)
  4. Agitation (state of anxiety or nervous excitement)
  5. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
6 - 12 months:
  1. Pre-existing condition improved
  2. Abortion spontaneous (naturally occurring miscarriage)
  3. Maternal exposure during pregnancy (use of substance during pregnancy)
  4. Sinusitis (inflammation of sinus)
  5. Therapeutic response unexpected
1 - 2 years:
  1. Embolic stroke (stroke due to obstruction due to an embolus)
  2. Fainting (loss of consciousness and postural tone)
  3. Thrombosis (formation of a blood clot inside a blood vessel)
  4. Breathing difficulty
  5. Pulmonary embolism (blockage of the main artery of the lung)
2 - 5 years:
  1. Injury
  2. Pain
  3. Constipation
  4. Cholecystitis chronic (long lasting infection of gallbladder)
  5. Abdominal pain upper
5 - 10 years:
  1. Osteopenia (a condition where bone mineral density is lower than normal)
  2. Scar
  3. Bone disorder
  4. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  5. Limb injury
10+ years:
  1. Uterine perforation (accidental puncture of the uterus)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Dizziness
  4. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  5. Malaise (a feeling of general discomfort or uneasiness)
not specified:
  1. Pain
  2. Nausea (feeling of having an urge to vomit)
  3. Dizziness
  4. Injury
  5. Headache (pain in head)

Top conditions involved for these people *:

  1. Birth Control : 52 people, 16.67%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 33 people, 10.58%
  3. Bipolar Disorder (mood disorder): 25 people, 8.01%
  4. Muscle Spasms (muscle contraction): 23 people, 7.37%
  5. Pain : 20 people, 6.41%

Top co-used drugs for these people *:

  1. Xyrem (61 people, 19.55%)
  2. Cymbalta (30 people, 9.62%)
  3. Yaz (26 people, 8.33%)
  4. Vicodin (24 people, 7.69%)
  5. Zofran (22 people, 7.05%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Related publications that referenced our studies

You may be interested in these posts

More posts for: Viibryd, Amphetamine salt combo, Xanax, Attention deficit hyperactivity disorder (adhd), Ptsd, Depression, Shortness of breath

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.